期刊文献+

草酸艾司西酞普兰的合成研究 被引量:2

Synthesis of Escitalopram Oxalate
原文传递
导出
摘要 目的合成抗抑郁药草酸艾司西酞普兰。方法以5-氰基苯酞为原料,经过两次格氏反应后水解,用(+)-DTTA拆分、成环后成盐而得到。结果所得产物结构经红外光谱、核磁共振氢谱及质谱确证。结论本方法合成工艺简单,合理可行。 OBJECTIVE To synthesize antidepressant drug of escitalopram oxalate.METHODS Escitalopram oxalate was synthesized from 5-cyanophthalide by twice grignard reaction,hydrolysis,the optical resolution with(+)-DTTA,cyclization and then salification.RESULTS The structure of the product was determined by IR,MS and 1H NMR spectra.CONCLUSION This procedure was simple,reasonable and feasible.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第18期1429-1431,共3页 Chinese Pharmaceutical Journal
关键词 艾司西酞普兰 抗抑郁药 合成 escitalopram antidepressant drug synthesis
  • 相关文献

参考文献7

  • 1SORBERA L A, MARTIN L, REVEL L, et al.Escitalopram oxalate[J]. Drugs Fut, 2001, 26(2): 115-120.
  • 2LAIS.Antidepressant drug:Escitalopram oxalate.世界临床药物,2003,24(12):762-763.
  • 3CONNIE S, MADS K. R-citalopram inhibits functional and 5-HTP- evoked behavioural responses to the SSRI, escitalopram [J]. Pharm Biochem Behav, 2004, 77(22):391-398.
  • 4DALL'ASTA L, CASAZZA U, PETERSEN H. Method for the preparation of citalopram: China, 1324351 [P]. 2001-11-28.
  • 5PITTELKOW T, CASTELLIN A, SBROGIO F, et al. Intermediates for the preparation of citaloprarn and escitalopram: China, 1761659[P]: 2006-04-19.
  • 6余红霞,郭峰.西酞普兰合成路线图解[J].中国医药工业杂志,2003,34(10):535-536. 被引量:14
  • 7COTTICELLI G, SALVETTI R. Process for the preparation of citalopram and escitalopram:USA, 7482477[P]:2007-11-22.

二级参考文献6

  • 1Dallasta L, Casazza U, Petersen H. Method for the preparation of citalopram[P]. WO:0023431,2000-04-27. (CA 2000,132:P308238d).
  • 2Petersen H, Bregnedal P, Bogeso KP. Method for the preparation o( citalopram[P]. WO : 9819513,1998-05-14. (CA 1998,129:P4572t).
  • 3Petersen H. Method for the preparation of citalopram[P]. WO: 9930548, 1999-06-24. (CA 1999, 131:P58745m).
  • 4Rock MH, Petersen H, Ellegaard P. Method for the preparation of citalopram [P]. WO : 00112044, 2000-03-09. (CA 2000,132=P207755q).
  • 5Petersen H, Rock MH, Svane H. Method for the preparation of citalopram[P]. WO : 0013648,2000-03-16. (CA 2000,132:P194283g).
  • 6Boegesoe KP, Tort AS. Phthalan derivatives[P].DE : 2657013,1977-07-28. (CA1977,87:P135040e)

共引文献13

同被引文献20

  • 1王来海,贾艳,黄素培.艾司西酞普兰[J].中国新药杂志,2005,14(6):790-792. 被引量:16
  • 2焦玉梅,孙莲芳,王立伟,章连生,陈剑华,周敏,施慎逊.抑郁症患者的血糖、血脂水平及其与症状关系的对照研究[J].上海精神医学,2006,18(5):266-269. 被引量:19
  • 3杨倩,刘文英,郑枫,徐继华,饶金华,孙棣,高暑.高效液相色谱-质谱-质谱联用法测定人血浆中艾司西酞普兰浓度及其药代动力学研究(英文)[J].中国临床药理学与治疗学,2006,11(10):1148-1153. 被引量:5
  • 4温预关,廖日房,曾转萍,邓超连.反相高效液相色谱法测定人血浆中艾司西酞普兰的浓度[J].广东药学院学报,2007,23(2):154-156. 被引量:4
  • 5新药速递[J]世界临床药物,2008(09).
  • 6C. Sánchez,P. B. F. Bergqvist,L. T. Brennum,S. Gupta,S. Hogg,A. Larsen,O. Wiborg.Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities[J]. Psychopharmacology . 2003 (4)
  • 7Von Moltke LL,Greenblatt DJ,Giancarlo GM,et al.Escitalpram (S - citalopram) and its metalolites in vitro:cytochromes mediating biotransformation,inhibitory iffects, and comparison to R - citalopram. Drug Metabolism and Disposition . 2009
  • 8Gutierrez MM,Rosenberg J,Abramowitz W.An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir. Clinical Therapeutics . 2008
  • 9Okamura F,Tashiro A,Utsumi A,et al.Insulin resistance in patientswith depression and its changes in the clinical course of depression;a report on thethreecases using theminimalmodel analysis. Journal of Internal Medicine . 1999
  • 10Mork A,Kreilgaaid M,Sanchez C.The R -enantiomer of citalopram counteracts escitalopram - induced increase in extracellular 5 - HT in the frontal cortex of freely moving rats. Neuropharmacology . 2008

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部